Abstract Details

Title Treatment with a Soluble Activin Receptor Type IIB Fusion Protein Reduces Serum Creatine Kinase Levels in Treadmill-Exercised mdx Mice

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 022

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jennifer Lachey (Acceleron Pharma)	No disclosure on file
Marcus W. Koch, MD, PhD (Marcus Koch)	No disclosure on file
	No disclosure on file
	No disclosure on file
Alan Koncarevic, PhD	No disclosure on file
Jasbir Seehra, PhD	Dr. Seehra has received personal compensation for serving as an employee of Keros Therapeutics. Dr. Seehra has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Modal Therapeutics. Dr. Seehra has or had stock in Keros Therapeutics.

��ɫ��